A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model
Nipah virus: Virus-like particles protect against major public health concern A vaccine candidate consisting of virus-like particles could offer the first effective prophylaxis against the deadly Nipah virus. Endemic to Malaysia, Bangladesh, and India, Nipah virus is contracted from infected fruit b...
Guardado en:
Autores principales: | Pramila Walpita, Yu Cong, Peter B. Jahrling, Oscar Rojas, Elena Postnikova, Shuiqing Yu, Lisa Johns, Michael. R. Holbrook |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c73ddbefeb8a401ca3556c3aba293d75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Thomas W. Geisbert, et al.
Publicado: (2021) -
A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
por: Erwan Atcheson, et al.
Publicado: (2021) -
Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model
por: Zhiying Yin, et al.
Publicado: (2021) -
Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule
por: Arbo,Antonio, et al.
Publicado: (2019) -
Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
por: Madison Crutcher, et al.
Publicado: (2021)